Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Denali Therapeutics Inc (NASDAQ: DNLI) was $13.83 for the day, up 1.17% from the previous closing price of $13.67. In other words, the price has increased by $1.17 from its previous closing price. On the day, 1.9 million shares were traded. DNLI stock price reached its highest trading level at $14.1294 during the session, while it also had its lowest trading level at $13.435.
Ratios:
Our analysis of DNLI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.56 and its Current Ratio is at 9.56. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $31.Deutsche Bank initiated its Buy rating on February 11, 2025, with a $31 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 09 ’25 when Watts Ryan J. sold 495,282 shares for $15.00 per share. The transaction valued at 7,429,230 led to the insider holds 253,071 shares of the business.
Watts Ryan J. bought 495,282 shares of DNLI for $7,097,391 on Jul 09 ’25. On Jan 06 ’25, another insider, Ho Carole, who serves as the Chief Medical Officer of the company, sold 12,255 shares for $20.22 each. As a result, the insider received 247,796 and left with 178,580 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DNLI now has a Market Capitalization of 2009167104 and an Enterprise Value of 1242816256.
Stock Price History:
The Beta on a monthly basis for DNLI is 1.35, which has changed by -0.3676269 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, DNLI has reached a high of $33.33, while it has fallen to a 52-week low of $10.57. The 50-Day Moving Average of the stock is -2.56%, while the 200-Day Moving Average is calculated to be -26.33%.
Shares Statistics:
DNLI traded an average of 1.49M shares per day over the past three months and 1498000 shares per day over the past ten days. A total of 145.25M shares are outstanding, with a floating share count of 125.73M. Insiders hold about 13.46% of the company’s shares, while institutions hold 92.49% stake in the company. Shares short for DNLI as of 1752537600 were 12682664 with a Short Ratio of 8.53, compared to 1749772800 on 11947808. Therefore, it implies a Short% of Shares Outstanding of 12682664 and a Short% of Float of 9.770001.
